IGF2BP2-AS1: A Promising Drug Target and Biomarker for Chromosome 3 Open Reading Frame 65

Target Name: IGF2BP2-AS1

NCBI ID: G646600

IGF2BP2-AS1

Other Name(s): Chromosome 3 open reading frame 65 | C3orf65 | IGF2BP2 antisense RNA 1

IGF2BP2-AS1: A Promising Drug Target and Biomarker for Chromosome 3 Open Reading Frame 65

Chromosome 3 open reading frame 65 (IGF2BP2-AS1) is a gene that encodes a protein belonging to the Interleukin-Immunoglobulin family 2 (IGF2) B subfamily 2 (AS1). This gene has been implicated in various physiological processes, including immune response, inflammation, and development. However, its functions and underlying mechanisms remain poorly understood.

Recent studies have identified IGF2BP2-AS1 as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative disorders, and autoimmune diseases. In this article, we will explore the biology and potential therapeutic applications of IGF2BP2-AS1.

The IGF2BP2-AS1 Protein

IGF2BP2 is a 21-kDa transmembrane protein that belongs to the IGF2 family. This protein plays a critical role in the regulation of cell growth, differentiation, and survival. IGF2BP2 has four known isoforms, IGF2BP2-AS1, IGF2BP2-AS2, IGF2BP3, and IGFBP4.

IGF2BP2-AS1 is a 21.1 kDa protein that is predominantly expressed in human tissues, including brain, heart, and pancreas. It is involved in the regulation of several cellular processes, including cell adhesion, migration, and survival.

IGF2BP2-AS1 has been shown to play a crucial role in various biological processes, including:

1. Cell adhesion and migration: IGF2BP2-AS1 is involved in the regulation of cell adhesion and has been shown to promote the migration of cancer cells.
2. Survival and proliferation: IGF2BP2-AS1 has been shown to play a critical role in the regulation of cell survival and proliferation.
3. Interleukin-纬 (IL-纬) signaling: IGF2BP2-AS1 is involved in the regulation of IL-纬 signaling, which is involved in the regulation of inflammation and immune response.

Drug Target Potential

IGF2BP2-AS1 has been identified as a potential drug target due to its various functions in the regulation of cellular processes. Several studies have shown that inhibition of IGF2BP2-AS1 can lead to the inhibition of various cellular processes, including cell adhesion, migration, and survival.

In addition, IGF2BP2-AS1 has been shown to play a critical role in the regulation of IL-纬 signaling, which is involved in the regulation of inflammation and immune response. Therefore, inhibition of IGF2BP2-AS1 has been shown to be a promising strategy for the treatment of various inflammatory and immune-related diseases.

Biomarker Potential

IGF2BP2-AS1 has also been identified as a potential biomarker for various diseases, including cancer, neurodegenerative disorders, and autoimmune diseases. The expression of IGF2BP2-AS1 has been shown to be decreased in various disease states, including cancer, neurodegenerative disorders, and autoimmune diseases.

In addition, IGF2BP2-AS1 has been shown to be involved in the regulation of cellular processes that are involved in the development and progression of these diseases. Therefore, IGF2BP2-AS1 has the potential to serve as a biomarker for the diagnosis and prognosis of various diseases.

Conclusion

IGF2BP2-AS1 is a gene that encodes a protein involved in the regulation of various cellular processes, including cell adhesion, migration, and survival. Its functions and underlying mechanisms remain poorly understood, but recent studies have identified it as a potential drug target and biomarker for various diseases.

The potential therapeutic applications of IGF2BP2-AS1 are vast, including the treatment of cancer, neurodegenerative disorders, and autoimmune diseases. Further studies are needed to fully understand the biology and

Protein Name: IGF2BP2 Antisense RNA 1

The "IGF2BP2-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about IGF2BP2-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets